Snegha Ananth

Snegha Ananth

Hematology | Oncology

505 S 45th St.
Omaha, NE 68105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.

Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.

Journal: Haematologica

Published: March 17, 2026

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.

Journal: American journal of hematology

Published: January 08, 2026

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy.

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy.

Journal: Blood advances

Published: February 27, 2025

The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).

The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).

Journal: Leukemia & lymphoma

Published: April 15, 2024

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient.

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient.

Journal: EJHaem

Published: January 09, 2024

The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration.

The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 07, 2023

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards.

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards.

Journal: The oncologist

Published: April 05, 2021

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.

Journal: Leukemia & lymphoma

Published: February 11, 2021

The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort.

The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort.

Journal: Journal of geriatric oncology

Published: November 02, 2019

Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis.

Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis.

Journal: BMJ case reports

Published: January 14, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026